期刊文献+

中医药通过肺淋巴管系统干预间质性肺疾病的研究进展 被引量:2

Research Progress of Intervention of Traditional Chinese Medicine on Interstitial Lung Disease through Pulmonary Lymphatic System
在线阅读 下载PDF
导出
摘要 间质性肺疾病(ILD)是一种以弥漫性肺实质的炎症和肺纤维化改变为特征的疾病。淋巴管系统在炎症和纤维化疾病中发挥重要作用。已知在炎症性疾病和纤维化疾病中淋巴管系统具有重要功能。但在间质性肺疾病中淋巴管系统作用的相关研究较少,随着科技的进步,逐渐发现了间质性肺疾病中肺淋巴管系统发挥作用的重要机制。且近年来运用中药疗法干预淋巴管系统来治疗疾病成为研究热点。现将基于肺淋巴管系统与间质性肺疾病中的相关性来探讨中医药对间质性肺疾病的干预作用。 Interstitial lung disease(ILD)is characterized by diffuse parenchymal lung inflammation and pulmonary fibrosis.The lymphatic system plays an important role in inflammation and fibrosis.The lymphatic system is known to have important functions in inflammatory and fibrotic diseases.However,there are few related studies on the role of the lymphatic system in interstitial lung diseases.With the advancement of science and technology,the important mechanism of the role of the pulmonary lymphatic system in interstitial lung diseases has been gradually discovered.In recent years,the use of Chinese medical therapy to intervene the lymphatic system to treat diseases has become a research hotspot.This paper will discuss the intervention effect of traditional Chinese medicine on ILD based on the correlation between the pulmonary lymphatic system and ILD.
作者 黄怡 石怡 木其尔 陈伟 HUANG Yi;SHI Yi;MU Qier;CHEN Wei(Longhua Hospital Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China)
出处 《世界中医药》 CAS 2023年第3期425-428,共4页 World Chinese Medicine
基金 上海市重大危重医疗事件中西医协同响应与干预平台建设项目(ZY2018-2020-FWTX-7004)。
关键词 间质性肺疾病 炎症 肺纤维化 肺淋巴管系统 作用机制 相关性 中药 干预作用 Interstitial lung disease Inflammation Pulmonary fibrosis Pulmonary lymphatic system Mechanism of action Correlation Traditional Chinese medicine Intervention effect
作者简介 黄怡(1989.08-),女,博士,住院医师,研究方向:中医药治疗危重病,E-mail:1192537540@qq.com;通信作者:陈伟(1961.07-),男,博士,主任医师,研究方向:中医药治疗危重病,E-mail:cwdoctor@163.com。
  • 相关文献

参考文献7

二级参考文献61

  • 1李建生,余学庆,胡金亮,程龙.中医证候标准建立的思路与方法[J].河南中医学院学报,2004(6):4-6. 被引量:102
  • 2江泳,张琦,高永波,徐建虎.防己黄芪汤拆方药对控制马兜铃酸肾毒性的初步研究[J].辽宁中医学院学报,2006,8(2):114-115. 被引量:5
  • 3苑慧清.肺痿(肺纤维化)治疗思路探讨[J].北京中医,1996,15(5):9-10. 被引量:38
  • 4王海彤,武维屏.中医药治疗弥漫性肺间质纤维化信息讨论[J].中国中医药信息杂志,1996,3(7):25-26. 被引量:39
  • 5Wells AU, Kelleher WP. Idiopathic pulmonary fibrosis pathogenesis and novel approaches to immunomodulation [ J]. Am J Respir Crit Care Med, 2013, 187(7) : 677 -679.
  • 6Stoia-Djeska I, Ceausu RA, Cimpean AM, et al. From basic lesions to a pathological staging of puhnonary fibrosis [ J ]. Rom J Morphol Embryol, 2013, 54(1) : 63 -69.
  • 7Cottin V. Changing the idiopathic pulmonary fibrosis treatment approach and improving patient outcomes [ J ]. Eur Respir Rev, 2012, 21(124) : 161 -167.
  • 8Richeldi L. Assessing the treatment effect from multiple trials in idiopathic pulmonary fibrosis [ J ]. Eur Respir Rev, 2012, 21 ( 124 ) : 147 - 151.
  • 9Szapiel SV, Elson NA, Fulmer JD, et al. Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse [ J ]. Am Rev Respir Dis, 1979, 120 (4) : 893 -899.
  • 10Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale [ J ]. J Clin Pathol, 1988, 41 (4) : 467 - 470.

共引文献159

同被引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部